London
· Delayed Price · Currency is GBP · Price in USD Bionano Genomics Statistics
Total Valuation
Bionano Genomics has a market cap or net worth of GBP 7.10 million. The enterprise value is 15.54 million.
| Market Cap | 7.10M |
| Enterprise Value | 15.54M |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +94.65% |
| Shares Change (QoQ) | +27.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.15 |
| EV / Sales | 0.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.22 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.43 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.24 |
| Interest Coverage | -20.21 |
Financial Efficiency
Return on equity (ROE) is -161.77% and return on invested capital (ROIC) is -65.04%.
| Return on Equity (ROE) | -161.77% |
| Return on Assets (ROA) | -48.42% |
| Return on Invested Capital (ROIC) | -65.04% |
| Return on Capital Employed (ROCE) | -191.70% |
| Revenue Per Employee | 72,298 |
| Profits Per Employee | -294,499 |
| Employee Count | 344 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -93.05% |
| 50-Day Moving Average | 12.89 |
| 200-Day Moving Average | 30.70 |
| Relative Strength Index (RSI) | 28.30 |
| Average Volume (20 Days) | 9,566 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 116.31 |
Income Statement
In the last 12 months, Bionano Genomics had revenue of GBP 24.87 million and -101.31 million in losses. Loss per share was -98.84.
| Revenue | 24.87M |
| Gross Profit | -446,914 |
| Operating Income | -77.82M |
| Pretax Income | -101.31M |
| Net Income | -101.31M |
| EBITDA | -66.47M |
| EBIT | -77.82M |
| Loss Per Share | -98.84 |
Balance Sheet
The company has 8.92 million in cash and 16.75 million in debt, giving a net cash position of -7.83 million.
| Cash & Cash Equivalents | 8.92M |
| Total Debt | 16.75M |
| Net Cash | -7.83M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 36.46M |
| Book Value Per Share | 24.73 |
| Working Capital | 10.47M |
Cash Flow
In the last 12 months, operating cash flow was -68.79 million and capital expenditures -632,693, giving a free cash flow of -69.42 million.
| Operating Cash Flow | -68.79M |
| Capital Expenditures | -632,693 |
| Free Cash Flow | -69.42M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -1.80% |
| Operating Margin | -312.92% |
| Pretax Margin | -407.35% |
| Profit Margin | n/a |
| EBITDA Margin | -267.26% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bionano Genomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.65% |
| Shareholder Yield | -94.65% |
| Earnings Yield | -1,427.32% |
| FCF Yield | -978.07% |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.0166666667.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0166666667 |
Scores
Bionano Genomics has an Altman Z-Score of -13.29. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.29 |
| Piotroski F-Score | n/a |